References
- Grunkemeier GL, Starr A, Rahimtoola SH, Prosthetic heart valve performance:long-term follow-up. Curr Prob Cardiol 1992; 17:331–406.
- Butchart EG. Prosthetic Heart Valves.Cardiovascular Thrombosis. Second edition. 1998; 395-414.
- Kulik A, Rubens FD, Wells PS, Kearon C, Mesana TG, van Berkom J, Lam BK. Early postoperative anticoagulation after mechanical valve replacement:a systematic review. Ann Thorac Surg2006 Feb; 81 (2):770–81.
- Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA. ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2008 Sep 23; 52 (13):e1-142.
- Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve:final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36:1152–8.tk;2
- Turpie AG, Gent M, Laupacis A. A comparison of aspirin with placebo in patients treated with Warfarin after heart-valve replacement. N Engl J Med 1993; 329:524 —9.
- Heras M, Chesebro SH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995; 25:1111–9.
- Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis:role of age and concomitant coronary artery disease. Chest 1993; 103:1715–9.
- Stein PD, Alpert SS, Copeland J, Dalen SE, Goldman S, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995;108 (suppl):s371-s379.
- Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin2006 Jun;22 (6):1109–22.
- Khamooshi AJ, Kashfi F, Hoseini S, Tababaei MB, Javadpour H, Noohi F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer? Asian Cardiovasc Thorac Ann2007 Dec; 15 (6):493–6.
- Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart 1994; 71:196–201.
- Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation 2003; 107:1240–6.
- Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure toanticoagulants during pregnancy. Am J MedGenet 1993; 45:17–21.
- Ginsberg SS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest1995; 108:3055–115.
- Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves:a double jeopardy. J Am Coll Cardiol 1996; 27:1704–6.
- Descarries LM, Leduc L, Khairy P, Mercier LA. Low molecular weight heparin in pregnant women with prosthetic heart valves. J. Heart Valve Dis2006 Sep; 15 (5):679–85
- Bates SM, Greer IA, Hirsh J, Ginsberg 3S. Use of antithrombotic agents during pregnancy:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:627S— 44S.